United Kingdom· GB-APID-42249711000001109
Hyftor 2mg/g gel
A sirolimus product containing sirolimus, registered in United Kingdom by Plusultra Pharma UK Ltd. The same ATC class is registered in 2 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Sirolimus is registered in 2 of 19 countries.
Countries holding a registration under ATC D11AX35 (sirolimus), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Sirolimus · ATC D11AX35
2 / 19 countries
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sirolimus costs, country by country.
Normalised to the WHO defined daily dose (0.8 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sirolimus · price per daily dose (0.8 mg)
USD · FX 28 Sept 2026
- ES Spain$4.09
- FR France$2.99
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Sirolimus
- Manufacturer
- Plusultra Pharma UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- D11AX35
- ATC class
- Sirolimus
- Defined daily dose
- 0.8 mg, T
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin4262416680009
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sirolimus in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandHyftorPlusultra pharma GmbH
- United StatesFYARROAadi Bioscience, Inc.
- CzechiaHYFTORPlusultra pharma GmbH, Düsseldorf
- SwitzerlandRapamune 0.5 mg, überzogene TablettenPfizer AG
- IrelandHYFTOR 2 mg/g GelPlusultra Pharma GmbH
- FinlandHyftorPlusultra Pharma GmbH
- BelgiumHyftor 2 mg/gPlusultra Pharma
- SwedenHyftor 2 mg/g GelPlusultra pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Sirolimus Panacea Biotec
- Iceland · Hyftor, Rapamune
- Liechtenstein · Hyftor, Rapamune
- Norway · Hyftor, Rapamune
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1ce42fd1-247c-490d-904b-987abcb62588 GET /v1/drugs/1ce42fd1-247c-490d-904b-987abcb62588?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "42249711000001109",
"desc": "Hyftor 2mg/g gel (Plusultra Pharma UK Ltd)",
"form": "Cutaneous gel",
"vpid": "42307211000001107",
"source": "dmd",
"vtm_id": "777539004",
"strength": "2 mg",
"substance": "Sirolimus",
"ingredient": "Sirolimus",
"supplier_code": "42239011000001106"
}See everything about sirolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.